位置:首页 > 蛋白库 > PFI_PTIFI
PFI_PTIFI
ID   PFI_PTIFI               Reviewed;         500 AA.
AC   Q8W257; Q8W256;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 1.
DT   03-AUG-2022, entry version 68.
DE   RecName: Full=Polyenoic fatty acid isomerase;
DE            Short=PFI;
DE            EC=5.3.3.13;
DE   Flags: Precursor;
OS   Ptilota filicina (Red alga).
OC   Eukaryota; Rhodophyta; Florideophyceae; Rhodymeniophycidae; Ceramiales;
OC   Ceramiaceae; Ptilota.
OX   NCBI_TaxID=153248;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Zheng W., Wise M.L., Wyrick A., Metz J.G., Yuan L., Gerwick W.H.;
RT   "Polyenoic fatty acid isomerase from the marine alga Ptilota filicina.";
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 22-59, FUNCTION, SUBUNIT,
RP   GLYCOSYLATION, AND COFACTOR.
RX   PubMed=12054482; DOI=10.1016/s0003-9861(02)00002-4;
RA   Zheng W., Wise M.L., Wyrick A., Metz J.G., Yuan L., Gerwick W.H.;
RT   "Polyenoic fatty acid isomerase from the marine alga Ptilota filicina:
RT   protein characterization and functional expression of the cloned cDNA.";
RL   Arch. Biochem. Biophys. 401:11-20(2002).
RN   [3]
RP   CATALYTIC ACTIVITY.
RX   PubMed=7803384; DOI=10.1021/bi00255a002;
RA   Wise M.L., Hamberg M., Gerwick W.H.;
RT   "Biosynthesis of conjugated triene-containing fatty acids by a novel
RT   isomerase from the red marine alga Ptilota filicina.";
RL   Biochemistry 33:15223-15232(1994).
RN   [4]
RP   CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=9062129; DOI=10.1021/bi962158v;
RA   Wise M.L., Rossi J., Gerwick W.H.;
RT   "Characterization of the substrate binding site of polyenoic fatty acid
RT   isomerase, a novel enzyme from the marine alga Ptilota filicina.";
RL   Biochemistry 36:2985-2992(1997).
CC   -!- FUNCTION: Involved in the biosynthesis of conjugated triene-containing
CC       fatty acids. Catalyzes the isomerization of a wide range of substrates
CC       containing three or more methylene interrupted olefins into a Z,E,E
CC       conjugated triene functionality. May be involved in a stress tolerance
CC       mechanism as response to intertidal habitats with direct sunlight,
CC       desiccation and high temperature. In vitro substrates include
CC       arachidonic acid ((5Z,8Z,11Z,14Z)-eicosatetraenoic acid), EPA ((5Z,8Z,
CC       11Z,14Z,17Z)-eicosapentaenoic acid), DHA ((4Z,7Z,10Z,13Z,16Z,19Z)-
CC       docosahexenoic acid), adrenic acid ((7Z,10Z,13Z,16Z)-docosatetraenoic
CC       acid), anandamide (arachidonyl-N-ethanolamide) and eicosatrienoic acid
CC       ((5Z,8Z,11Z)-eicosatrienoic acid). Gamma-linolenic acid (18:3
CC       6Z,9Z,12Z) and dihomo-gamma-linolenic acid (20:3 8Z,11Z,14Z) are
CC       transformed into mixtures of conjugated diene and triene fatty acids,
CC       linoleic acid is only transformed to a conjugated diene.
CC       {ECO:0000269|PubMed:12054482}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoate = (5Z,7E,9E,14Z,17Z)-
CC         icosapentaenoate; Xref=Rhea:RHEA:14889, ChEBI:CHEBI:58562,
CC         ChEBI:CHEBI:60025; EC=5.3.3.13; Evidence={ECO:0000269|PubMed:7803384,
CC         ECO:0000269|PubMed:9062129};
CC   -!- COFACTOR:
CC       Name=an oxidized flavin; Xref=ChEBI:CHEBI:60531;
CC         Evidence={ECO:0000305|PubMed:12054482};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.9 uM for (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexenoic acid
CC         {ECO:0000269|PubMed:9062129};
CC         KM=17.0 uM for (7Z,10Z,13Z,16Z)-docosatetraenoic acid
CC         {ECO:0000269|PubMed:9062129};
CC         KM=9.6 uM for (5Z,8Z, 11Z,14Z,17Z)-eicosapentaenoic acid
CC         {ECO:0000269|PubMed:9062129};
CC         KM=25.5 uM for (5Z,8Z,11Z,14Z)-eicosatetraenoic acid
CC         {ECO:0000269|PubMed:9062129};
CC         KM=52.8 uM for (5Z,8Z,11Z)-eicosatrienoic acid
CC         {ECO:0000269|PubMed:9062129};
CC         KM=17.5 uM for arachidonyl-N-ethanolamide
CC         {ECO:0000269|PubMed:9062129};
CC         Vmax=1.84 umol/min/mg enzyme with (4Z,7Z,10Z,13Z,16Z,19Z)-
CC         docosahexenoic acid as substrate {ECO:0000269|PubMed:9062129};
CC         Vmax=1.1 umol/min/mg enzyme with (7Z,10Z,13Z,16Z)-docosatetraenoic
CC         acid as substrate {ECO:0000269|PubMed:9062129};
CC         Vmax=6.0 umol/min/mg enzyme with (5Z,8Z, 11Z,14Z,17Z)-
CC         eicosapentaenoic acid as substrate {ECO:0000269|PubMed:9062129};
CC         Vmax=2.78 umol/min/mg enzyme with (5Z,8Z,11Z,14Z)-eicosatetraenoic
CC         acid as substrate {ECO:0000269|PubMed:9062129};
CC         Vmax=0.31 umol/min/mg enzyme with (5Z,8Z,11Z)-eicosatrienoic acid as
CC         substrate {ECO:0000269|PubMed:9062129};
CC         Vmax=0.8 umol/min/mg enzyme with arachidonyl-N-ethanolamide as
CC         substrate {ECO:0000269|PubMed:9062129};
CC       pH dependence:
CC         Optimum pH is below pH 6.0 with (5Z,8Z,11Z,14Z,17Z)-eicosapentaenoic
CC         acid as substrate. {ECO:0000269|PubMed:9062129};
CC   -!- SUBUNIT: Homodimer. {ECO:0000305|PubMed:12054482}.
CC   -!- PTM: Glycosylated. {ECO:0000269|PubMed:12054482}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF354661; AAL57199.1; -; mRNA.
DR   EMBL; AF354662; AAL57200.1; -; mRNA.
DR   AlphaFoldDB; Q8W257; -.
DR   SMR; Q8W257; -.
DR   PRIDE; Q8W257; -.
DR   KEGG; ag:AAL57199; -.
DR   GO; GO:0016491; F:oxidoreductase activity; IEA:InterPro.
DR   GO; GO:0034016; F:polyenoic fatty acid isomerase activity; IEA:UniProtKB-EC.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR002937; Amino_oxidase.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   Pfam; PF01593; Amino_oxidase; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Isomerase; Signal.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000269|PubMed:12054482"
FT   CHAIN           22..500
FT                   /note="Polyenoic fatty acid isomerase"
FT                   /id="PRO_0000418869"
FT   CONFLICT        56..57
FT                   /note="ES -> SQ (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        59
FT                   /note="G -> Y (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        327..328
FT                   /note="AD -> TN (in Ref. 1; AAL57200)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        367
FT                   /note="N -> D (in Ref. 1; AAL57200)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        477
FT                   /note="S -> A (in Ref. 1; AAL57200)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   500 AA;  55960 MW;  F2825B6F515DBD7D CRC64;
     MSLNRVLHIF LIAYLACTAL THDFDDTIAV VGAGYSGLSA AFTLVKKGYT NVEIYESQGE
     VGGYVYSVDY NNVAHDLATY ALTPAYWKFQ EAMKSIGVGF CELDVAIVQT NSTPVSVPFE
     KWMAAYWAAK VPNPLNLVRK VSTQVSTYVE VWKKLFNMDF IDTSTKRTNR LFPLKTNDVD
     VLAQFSMPMK DFVALHKLDL LEPLFIQATD SQAYGPYDTT PALYYMVWFP PNLFNGEENT
     VPCGTYNSMQ SMAEHMAEWL KSKGVTFHMN TKVTKISRAT DGSSPSLLEE GVATPKLFDT
     IISTNKLPSA NRAEVVTPLL PKEREAADTY EELQMFSALL ETNRSDAIPT TGFLMVDADA
     IIAHDPNTGF WGCLNAERRG GYSDENAILS SDTVTRVSAI YYYTERANNE RIDFSLDEKI
     QQVKTNLATW DSATWTNLTS RTFGGYFQRW RTPDVMGQKP WNLADIQGEG DVYYVNSAAC
     GFESVGHVFD CADNLIKDFF
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024